A nurse is caring for a client who is at risk for shock. Which of the following findings is the earliest indicator that this complication is developing?

Choice A Reason: This is incorrect because magnesium is not a medication for symptomatic bradycardia. Magnesium is a mineral that regulates muscle and nerve function, blood pressure, and blood sugar levels. Magnesium can be used to treat conditions such as torsades de pointes, eclampsia, or hypomagnesemia.

Choice B Reason: This is incorrect because sodium bicarbonate is not a medication for symptomatic bradycardia. Sodium bicarbonate is a substance that neutralizes acids and bases and regulates the pH of the blood. Sodium bicarbonate can be used to treat conditions such as metabolic acidosis, cardiac arrest, or overdose of certain drugs.

Choice C Reason: This is incorrect because epinephrine is not a medication for symptomatic bradycardia. Epinephrine is a hormone that activates the sympathetic nervous system and increases the heart rate, blood pressure, and blood flow to the muscles and brain. Epinephrine can be used to treat conditions such as anaphylaxis, cardiac arrest, or severe asthma.

Choice D Reason: This is correct because atropine is a medication for symptomatic bradycardia. Atropine blocks the action of the parasympathetic nervous system and increases the heart rate and conduction. Atropine is a medication that blocks the action of the parasympathetic nervous system and increases the heart rate and conduction.

Symptomatic bradycardia is a condition where the heart rate is slower than normal and causes symptoms such as dizziness, fatigue, chest pain, or fainting. Atropine can be used to treat symptomatic bradycardia by stimulating the sinoatrial node and the atrioventricular node, which are the natural pacemakers of the heart.

The correct answer is: C. Continue the rate at 125 mL/hr.
Choice A: Slow the rate to 50 mL/hr
Slowing the IV fluid rate to 50 mL/hr is not appropriate for a patient with a head injury. Adequate fluid management is crucial to maintain cerebral perfusion pressure and prevent secondary brain injury. Reducing the rate to 50 mL/hr could lead to hypovolemia, which might decrease cerebral perfusion and worsen the patient’s condition.
Choice B: Slow the rate to 20 mL/hr
Slowing the IV fluid rate to 20 mL/hr is even less appropriate. Such a low rate would likely result in significant hypovolemia, severely compromising cerebral perfusion pressure. This could exacerbate the patient’s head injury by reducing the blood flow to the brain, leading to further damage.
Choice C: Continue the rate at 125 mL/hr
Continuing the rate at 125 mL/hr is appropriate. This rate helps maintain euvolemia, which is essential for ensuring adequate cerebral perfusion pressure in patients with head injuries. Maintaining a stable fluid rate helps prevent both hypovolemia and hypervolemia, both of which can negatively impact intracranial pressure and cerebral perfusion.
Choice D: Increase the rate to 250 mL/hr
Increasing the IV fluid rate to 250 mL/hr is not recommended. Overhydration can lead to increased intracranial pressure, which can be detrimental to a patient with a head injury. Excessive fluid administration can cause cerebral edema, worsening the patient’s condition.